VAERS reports by lot

Pfizer RSV lot HM9865: VAERS reports

23 VAERS reports list lot HM9865 as a Pfizer RSV vaccine, received between 2024-02-21 and 2024-11-18. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
9%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Musculoskeletal825%
Injection-site / Local reaction619%
Cardiac / Cardiovascular412%
Respiratory39%
General / Systemic (non-local)39%
Neurological26%
Allergic / Anaphylactic26%
Dermatological (non-injection-site)26%
Autoimmune / Immune-mediated13%
Gastrointestinal13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania3
California2
Colorado2
Kentucky2
Michigan2
Tennessee1
New Jersey1
Illinois1
Connecticut1
North Dakota1
Indiana1
Oklahoma1

Reports by month received

2024-021
2024-032
2024-062
2024-072
2024-081
2024-097
2024-106
2024-112

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.